Peter Winocour Selected Research

Peter Winocour Research Topics

3	Diabetes Mellitus 01/2021 - 04/2008
2	Type 2 Diabetes Mellitus (MODY) 04/2022 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 12/2010
2	Diabetic Nephropathies (Diabetic Nephropathy) 03/2011 - 04/2008
2	Hyperglycemia 04/2009 - 04/2008
1	Hypertension (High Blood Pressure) 04/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021
1	Starvation 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Body Weight (Weight, Body) 12/2011
1	Anemia 04/2009
1	Hypoxia (Hypoxemia) 04/2008
1	Neoplasms (Cancer) 11/2005

3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	SymportersIBA 01/2021 - 01/2018
2	SodiumIBA 01/2021 - 01/2018
2	Erythropoietin FDA Link 09/2009 - 04/2009
1	AngiotensinsIBA 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	ReninIBA 04/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	dapagliflozinIBA 01/2021
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	CholesterolIBA 12/2011
1	LipidsIBA 03/2011
1	OsteoprotegerinIBA 12/2010
1	1,25-dihydroxyvitamin DIBA 09/2009
1	Hemoglobins (Hemoglobin)IBA 04/2009
1	AEG 35156IBA 11/2005

1	Caloric Restriction 01/2021
1	Organ Transplantation 01/2021
1	Glycemic Control 03/2011
1	Therapeutics 03/2011
1	Sympathectomy (Sympathectomies) 04/2008